You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 159 No. 10, May 24, 1999 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (204)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Lipids and Lipid Disorders
 •Alert me on articles by topic

Clustering of Metabolic Factors and Coronary Heart Disease

Peter W. F. Wilson, MD; William B. Kannel, MD; Halit Silbershatz, PhD; Ralph B. D'Agostino, PhD

Arch Intern Med. 1999;159:1104-1109.

Background  The degree of clustering for common metabolic coronary disease risk factors is not well known, the antecedents of clustering are not well studied, and the impact of such clusters on coronary risk has not been assessed systematically.

Methods  Prospective community sample of 2406 men and 2569 women aged 18 to 74 years at baseline. The 6 metabolically linked risk factors considered were the lowest sex-specific quintile of high-density lipoprotein cholesterol and the highest quintiles of body mass index, systolic blood pressure, triglycerides, glucose, and serum total cholesterol.

Results  At baseline the risk factor sum, represented as integer values, ranged from 0 to 6, and clusters of 3 or more risk factors occurred at twice the rate predicted by chance. After adjustment for age and obesity level, a 2.25-kg (5-lb) weight increase over 16 years was associated with an increased risk factor sum in men (+20%; P=.002) and women (+37%; P<.001), and a 2.25-kg weight loss was associated with a decreased risk factor sum in men (-48%; P<.001) and women (-40%; P<.001). Clusters of 3 or more risk factors were associated with a 2.39 (95% confidence interval, 1.56-3.36) and 5.90 (95% confidence interval, 2.54-13.73) times greater risk of coronary heart disease in men and women, respectively (both P<.001).

Conclusions  Atherogenic risk factor clustering is common in both sexes, worsens with weight gain, and is associated with greatly increased risk of coronary disease risk in both sexes.


From the National Heart, Lung, and Blood Institute, Framingham Heart Study, Framingham, Mass (Dr Wilson), Framingham Heart Study, Boston University School of Medicine (Dr Kannel), and Department of Mathematics, Boston University (Drs Silbershatz and D'Agostino), Boston, Mass.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Co-occurrence of risk factors for cardiovascular disease by social class: 1958 British birth cohort
Power et al.
J. Epidemiol. Community Health 2008;62:1030-1035.
ABSTRACT | FULL TEXT  

Metabolic Syndrome, Inflammation, and Incident Heart Failure in the Elderly: The Cardiovascular Health Study
Suzuki et al.
Circ Heart Fail 2008;1:242-248.
ABSTRACT | FULL TEXT  

Metabolic Syndrome Affects Cardiovascular Risk Profile and Response to Treatment in Hypertensive Postmenopausal Women
Rossi et al.
Hypertension 2008;52:865-872.
ABSTRACT | FULL TEXT  

Changes in Body Weight Predict CKD in Healthy Men
Ryu et al.
J. Am. Soc. Nephrol. 2008;19:1798-1805.
ABSTRACT | FULL TEXT  

Body Size and Renal Cell Cancer Incidence in a Large US Cohort Study
Adams et al.
Am J Epidemiol 2008;168:268-277.
ABSTRACT | FULL TEXT  

Lifestyle and Risk of Cardiovascular Disease and Type 2 Diabetes in Women: A Review of the Epidemiologic Evidence
Bassuk and Manson
AMERICAN JOURNAL OF LIFESTYLE MEDICINE 2008;2:191-213.
ABSTRACT  

Protein in optimal health: heart disease and type 2 diabetes
Layman et al.
Am. J. Clin. Nutr. 2008;87:1571S-1575S.
ABSTRACT | FULL TEXT  

Physical Activity: Physical Activity and the Metabolic Syndrome: A Review of the Evidence
Churilla and Zoeller
AMERICAN JOURNAL OF LIFESTYLE MEDICINE 2008;2:118-125.
ABSTRACT  

The Metabolic Syndrome: More Than the Sum of Its Components?
Kurth and Logroscino
Stroke 2008;39:1068-1069.
FULL TEXT  

Metabolic syndrome and the menopause
Kaaja
Menopause Int 2008;14:21-25.
ABSTRACT | FULL TEXT  

Cardiovascular risk factors in adult patients with multisystem Langerhans-cell histiocytosis: evidence of glucose metabolism abnormalities
Alexandraki et al.
QJM 2008;101:31-40.
ABSTRACT | FULL TEXT  

Metabolic Syndrome and Ischemic Stroke Risk: Northern Manhattan Study
Boden-Albala et al.
Stroke 2008;39:30-35.
ABSTRACT | FULL TEXT  

Prevalence of Colorectal Neoplasm Among Patients With Newly Diagnosed Coronary Artery Disease
Chan et al.
JAMA 2007;298:1412-1419.
ABSTRACT | FULL TEXT  

Metformin administration improves leukocyte count in women with polycystic ovary syndrome: a 6-month prospective study
Orio et al.
Eur J Endocrinol 2007;157:69-73.
ABSTRACT | FULL TEXT  

Independent associations of insulin resistance with high whole-body intermuscular and low leg subcutaneous adipose tissue distribution in obese HIV-infected women
Albu et al.
Am. J. Clin. Nutr. 2007;86:100-106.
ABSTRACT | FULL TEXT  

Relationship Between Metabolic Risk Factor Clustering and Cardiovascular Mortality Stratified by High Blood Glucose and Obesity: NIPPON DATA90, 1990-2000
Kadota et al.
Diabetes Care 2007;30:1533-1538.
ABSTRACT | FULL TEXT  

Absolute and Attributable Risks of Cardiovascular Disease Incidence in Relation to Optimal and Borderline Risk Factors: Comparison of African American With White Subjects--Atherosclerosis Risk in Communities Study
Hozawa et al.
Arch Intern Med 2007;167:573-579.
ABSTRACT | FULL TEXT  

Metabolic Syndrome and Risk of Incident Cardiovascular Events and Death: A Systematic Review and Meta-Analysis of Longitudinal Studies
Gami et al.
J Am Coll Cardiol 2007;49:403-414.
ABSTRACT | FULL TEXT  

Risk Profiles for Metabolic Syndrome in a Nonclinical Sample of Adolescent Girls
Ventura et al.
Pediatrics 2006;118:2434-2442.
ABSTRACT | FULL TEXT  

Benefits, challenges, and registerability of the polypill
Sleight et al.
Eur Heart J 2006;27:1651-1656.
ABSTRACT | FULL TEXT  

Clinical Use of the Metabolic Syndrome: Why the Confusion?
Blaha and Elasy
Clin. Diabetes 2006;24:125-131.
ABSTRACT | FULL TEXT  

Adiposity in Youth and Blood Pressure
Wilson
Hypertension 2006;48:21-22.
FULL TEXT  

Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin
Diamanti-Kandarakis et al.
Hum Reprod 2006;21:1426-1431.
ABSTRACT | FULL TEXT  

The Changing Face of Dyslipidemia Therapies
Rochester and Cooke
Journal of Pharmacy Practice 2006;19:79-93.
ABSTRACT  

Renal Manifestations in the Metabolic Syndrome.
Locatelli et al.
J. Am. Soc. Nephrol. 2006;17:S81-S85.
ABSTRACT | FULL TEXT  

Manifestations of Chronic Disease During Pregnancy
Kaaja and Greer
JAMA 2005;294:2751-2757.
ABSTRACT | FULL TEXT  

Educational disparities in the metabolic syndrome in a rapidly changing society--the case of South Korea
Kim et al.
Int J Epidemiol 2005;34:1266-1273.
ABSTRACT | FULL TEXT  

'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus
Bruce
Rheumatology (Oxford) 2005;44:1492-1502.
ABSTRACT | FULL TEXT  

Metabolic Syndrome as a Precursor of Cardiovascular Disease and Type 2 Diabetes Mellitus
Wilson et al.
Circulation 2005;112:3066-3072.
ABSTRACT | FULL TEXT  

Obesity in older adults: technical review and position statement of the American Society for Nutrition and NAASO, The Obesity Society
Villareal et al.
Am. J. Clin. Nutr. 2005;82:923-934.
ABSTRACT | FULL TEXT  

What is the relationship between risk factor reduction and degree of weight loss?
Van Gaal et al.
Eur Heart J Suppl 2005;7:L21-L26.
ABSTRACT | FULL TEXT  

An Exploratory Analysis of Criteria for the Metabolic Syndrome and Its Prediction of Long-term Cardiovascular Outcomes: The Hoorn Study
Girman et al.
Am J Epidemiol 2005;162:438-447.
ABSTRACT | FULL TEXT  

11{beta}-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice
Hermanowski-Vosatka et al.
JEM 2005;202:517-527.
ABSTRACT | FULL TEXT  

Bezafibrate for the Secondary Prevention of Myocardial Infarction in Patients With Metabolic Syndrome
Tenenbaum et al.
Arch Intern Med 2005;165:1154-1160.
ABSTRACT | FULL TEXT  

Metformin administration improves endothelial function in women with polycystic ovary syndrome
Diamanti-Kandarakis et al.
Eur J Endocrinol 2005;152:749-756.
ABSTRACT | FULL TEXT  

The Metabolic Syndrome, Cardiopulmonary Fitness, and Subcutaneous Trunk Fat as Independent Determinants of Arterial Stiffness: The Amsterdam Growth and Health Longitudinal Study
Ferreira et al.
Arch Intern Med 2005;165:875-882.
ABSTRACT | FULL TEXT  

Abdominal adipose tissue cytokine gene expression: relationship to obesity and metabolic risk factors
You et al.
Am. J. Physiol. Endocrinol. Metab. 2005;288:E741-E747.
ABSTRACT | FULL TEXT  

Presence of the Metabolic Syndrome Does Not Impair Coronary Collateral Vessel Formation in Patients With Documented Coronary Artery Disease
Olijhoek et al.
Diabetes Care 2005;28:683-689.
ABSTRACT | FULL TEXT  

Development of Fatness, Fitness, and Lifestyle From Adolescence to the Age of 36 Years: Determinants of the Metabolic Syndrome in Young Adults: The Amsterdam Growth and Health Longitudinal Study
Ferreira et al.
Arch Intern Med 2005;165:42-48.
ABSTRACT | FULL TEXT  

The Increase of Leukocytes as a New Putative Marker of Low-Grade Chronic Inflammation and Early Cardiovascular Risk in Polycystic Ovary Syndrome
Orio et al.
J. Clin. Endocrinol. Metab. 2005;90:2-5.
ABSTRACT | FULL TEXT  

Decreased Recognition of the Post-Myocardial Infarction (Dressler) Syndrome in the Postinfarct Setting: Does It Masquerade as "Idiopathic Pericarditis" Following Silent Infarcts?
Spodick
Chest 2004;126:1410-1411.
FULL TEXT  

Risk Factors for the Metabolic Syndrome: The Coronary Artery Risk Development in Young Adults (CARDIA) study, 1985-2001
Carnethon et al.
Diabetes Care 2004;27:2707-2715.
ABSTRACT | FULL TEXT  

Role of Oxidative Modifications in Atherosclerosis
Stocker and Keaney
Physiol. Rev. 2004;84:1381-1478.
ABSTRACT | FULL TEXT  

Heritability and correlates of intercellular adhesion molecule-1 in the Framingham Offspring Study
Keaney et al.
J Am Coll Cardiol 2004;44:168-173.
ABSTRACT | FULL TEXT  

Prevalence of the Metabolic Syndrome and Its Relation to All-Cause and Cardiovascular Mortality in Nondiabetic European Men and Women
Hu et al.
Arch Intern Med 2004;164:1066-1076.
ABSTRACT | FULL TEXT  

Relation Between Leptin and the Metabolic Syndrome in Elderly Women
Zamboni et al.
J. Gerontol. A Biol. Sci. Med. Sci. 2004;59:M396-M400.
ABSTRACT | FULL TEXT  

Clinical Importance of Obesity Versus the Metabolic Syndrome in Cardiovascular Risk in Women: A Report From the Women's Ischemia Syndrome Evaluation (WISE) Study
Kip et al.
Circulation 2004;109:706-713.
ABSTRACT | FULL TEXT  

The Metabolic Syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm
Olijhoek et al.
Eur Heart J 2004;25:342-348.
ABSTRACT | FULL TEXT  

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
Chobanian et al.
Hypertension 2003;42:1206-1252.
ABSTRACT | FULL TEXT  

The Metabolic Syndrome: A Practical Guide to Origins and Treatment: Part II
Wilson and Grundy
Circulation 2003;108:1537-1540.
FULL TEXT  

The effect of diabetes on outcomes of patients with advanced heart failure in the BEST trial
Domanski et al.
J Am Coll Cardiol 2003;42:914-922.
ABSTRACT | FULL TEXT  

The Metabolic Syndrome and Antioxidant Concentrations: Findings From the Third National Health and Nutrition Examination Survey
Ford et al.
Diabetes 2003;52:2346-2352.
ABSTRACT | FULL TEXT  

Prevalence and Characteristics of the Metabolic Syndrome in the San Antonio Heart and Framingham Offspring Studies
Meigs et al.
Diabetes 2003;52:2160-2167.
ABSTRACT | FULL TEXT  

The metabolic syndrome
Meigs
BMJ 2003;327:61-62.
FULL TEXT  

The Emergence of the Metabolic Syndrome with Menopause
Carr
J. Clin. Endocrinol. Metab. 2003;88:2404-2411.
ABSTRACT | FULL TEXT  

Disparities in Use of Lipid-Lowering Medications Among People With Type 2 Diabetes Mellitus
Safford et al.
Arch Intern Med 2003;163:922-928.
ABSTRACT | FULL TEXT  

A Comparison of the Prevalence of the Metabolic Syndrome Using Two Proposed Definitions
Ford and Giles
Diabetes Care 2003;26:575-581.
ABSTRACT | FULL TEXT  

What to Do About the Metabolic Syndrome?
Hill and Bessesen
Arch Intern Med 2003;163:395-397.
FULL TEXT  

The Metabolic Syndrome: Prevalence and Associated Risk Factor Findings in the US Population From the Third National Health and Nutrition Examination Survey, 1988-1994
Park et al.
Arch Intern Med 2003;163:427-436.
ABSTRACT | FULL TEXT  

Thiazolidinediones Could Improve Endothelial Dysfunction and Risk of Premature Coronary Heart Disease in HIV-Infected Patients
Carrillo-Jimenez et al.
J CARDIOVASC PHARMACOL THER 2002;7:207-210.
ABSTRACT  

Obesity, Hypertension, and Insulin Resistance
Bloomgarden
Diabetes Care 2002;25:2088-2097.
FULL TEXT  

A Waist Is a Terrible Thing to Mind : Central Obesity, the Metabolic Syndrome, and Sleep Apnea Hypopnea Syndrome
Brown
Chest 2002;122:774-778.
FULL TEXT  

Task Force #1--magnitude of the prevention problem: opportunities and challenges
Benjamin et al.
J Am Coll Cardiol 2002;40:588-603.
FULL TEXT  

Predictability of Childhood Adiposity and Insulin for Developing Insulin Resistance Syndrome (Syndrome X) in Young Adulthood: The Bogalusa Heart Study
Srinivasan et al.
Diabetes 2002;51:204-209.
ABSTRACT | FULL TEXT  

Increased Endothelin-1 Levels in Women with Polycystic Ovary Syndrome and the Beneficial Effect of Metformin Therapy
Diamanti-Kandarakis et al.
J. Clin. Endocrinol. Metab. 2001;86:4666-4673.
ABSTRACT | FULL TEXT  

Updated Guidelines for Cholesterol Management
Lauer and Fontanarosa
JAMA 2001;285:2508-2509.
FULL TEXT  

Update in Women's Health
Walsh et al.
ANN INTERN MED 2000;133:808-814.
FULL TEXT  

Invited Commentary: Insulin Resistance Syndrome? Syndrome X? Multiple Metabolic Syndrome? A Syndrome At All? Factor Analysis Reveals Patterns in the Fabric of Correlated Metabolic Risk Factors
Meigs
Am J Epidemiol 2000;152:908-911.
ABSTRACT | FULL TEXT  

How deadly is the "deadly quartet"?: A post-CABG evaluation
Sprecher and Pearce
J Am Coll Cardiol 2000;36:1159-1165.
ABSTRACT | FULL TEXT  

The VA HDL Intervention Trial: clinical implications
Rubins et al.
Eur Heart J 2000;21:1113-1115.
 

Normal Endothelial Function Despite Insulin Resistance in Healthy Women with the Polycystic Ovary Syndrome
Mather et al.
J. Clin. Endocrinol. Metab. 2000;85:1851-1856.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.